Table 11.6i
Immunosuppression Use for Antirejection Treatment from Transplant
to One Year Following Transplantation, 1994 to 2003
Recipients with Heart Transplants
| 2,340 |
2,363 |
2,343 |
2,293 |
2,348 |
2,188 |
2,199 |
2,202 |
2,155 |
2,057 |
| 934 |
955 |
854 |
871 |
979 |
916 |
900 |
851 |
801 |
654 |
| 22.7% |
20.8% |
18.1% |
19.3% |
21.2% |
17.7% |
16.3% |
15.5% |
17.5% |
18.5% |
| 1.8% |
0.4% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| 7.7% |
8.1% |
5.4% |
7.9% |
7.3% |
6.3% |
4.6% |
3.9% |
4.0% |
4.6% |
| 16.7% |
14.5% |
13.9% |
13.1% |
14.9% |
7.4% |
5.1% |
5.8% |
6.9% |
4.1% |
| 0.0% |
0.0% |
0.0% |
0.1% |
0.2% |
2.0% |
3.8% |
4.9% |
6.4% |
7.5% |
| 0.0% |
0.0% |
0.0% |
0.1% |
0.8% |
2.5% |
3.0% |
2.5% |
1.5% |
2.0% |
| 0.0% |
0.0% |
0.0% |
0.0% |
0.1% |
0.9% |
2.0% |
0.4% |
0.4% |
1.4% |
| 89.4% |
92.6% |
88.3% |
88.6% |
87.9% |
91.3% |
92.3% |
92.7% |
92.0% |
92.5% |
| 89.4% |
92.6% |
88.3% |
88.6% |
87.9% |
91.3% |
92.3% |
92.7% |
92.0% |
92.5% |
| 7.7% |
6.6% |
5.4% |
7.6% |
6.5% |
4.6% |
4.4% |
2.0% |
2.9% |
3.5% |
| 1.4% |
1.8% |
1.8% |
3.6% |
2.5% |
2.1% |
1.7% |
0.5% |
0.9% |
1.7% |
| 6.3% |
4.9% |
3.6% |
4.1% |
4.3% |
2.6% |
2.8% |
1.5% |
2.0% |
1.8% |